Delivery Order SPE2DB25D3202-SPE2DB26FSZFA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,316.42 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,907.65 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count units). The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, utilizes firm fixed-price pricing with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,485.09 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count units). This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on October 17, 2025, with an ultimate completion date of October 20, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.28 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance of this delivery order will occur at the contractor's location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,305.54 by the Defense Logistics Agency (DLA) on October 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,430.14 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed price contract represents a non-set-aside procurement and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,080.55 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,513.10, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100 count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of October 31, 2025, issued on October 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg tablets (100-count) valued at $1,000.16, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB26FSZFADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100 count) valued at $1,016.28 under a firm fixed price arrangement. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under the company's broader pharmaceutical supply relationship with the federal government, which encompasses a wide portfolio of medications and medical supplies supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp holds a significant $999.99 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical running through December 2026, which serves as the umbrella vehicle for this and similar pharmaceutical delivery orders. As a major pharmaceutical distributor, AmerisourceBergen supplies medications across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally. The current delivery order for controlled substance amphetamine tablets represents routine pharmaceutical provisioning under this established prime vendor arrangement, which is expected to evolve as DLA plans to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards in the coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/27/25 |